Published in J Urol on September 01, 2006
Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer. BJU Int (2008) 1.04
Using biopsy to detect prostate cancer. Rev Urol (2008) 1.00
Saturation biopsies for prostate cancer: current uses and future prospects. Nat Rev Urol (2009) 0.95
Focal therapy for prostate cancer: The current status. Prostate Int (2015) 0.86
Pathologic basis of focal therapy for early-stage prostate cancer. Nat Rev Urol (2009) 0.83
Pathology: the lottery of conventional prostate biopsy. Nat Rev Urol (2009) 0.82
Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer. Urol Oncol (2011) 0.79
Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen. Prostate Cancer Prostatic Dis (2008) 0.77
Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study. Asian J Androl (2015) 0.75
Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol. World J Urol (2011) 0.75
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol (2001) 2.87
Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol (2002) 2.34
Radical prostatectomy for prostate cancer: the perineal approach increases the risk of surgically induced positive margins and capsular incisions. J Urol (1998) 1.66
Clinical and anatomical spectrum in XX sex reversed patients. Relationship to the presence of Y specific DNA-sequences. Clin Endocrinol (Oxf) (1994) 1.18
Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol (2000) 1.15
Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Eur Urol (2005) 1.10
Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer. Clin Chem (1999) 1.07
Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int (2001) 1.06
High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res (1996) 1.05
Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence. J Urol (1996) 1.03
Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate (2001) 1.00
Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch Pathol Lab Med (1997) 1.00
A possible common origin of "Y-negative" human XX males and XX true hermaphrodites. Hum Genet (1990) 0.99
Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer. Eur Urol (1999) 0.95
Absence of microsatellite instability in transitional cell carcinoma of the bladder. Urology (2000) 0.93
Scleritis and mucosal-associated lymphoid tissue lymphoma: a new masquerade syndrome. Ophthalmology (1996) 0.93
The management of stress urinary incontinence after radical prostatectomy. BJU Int (2002) 0.92
Overwhelming strongyloidiasis in a diabetic patient following ACTH treatment and keto-acidosis. Diabete Metab (1988) 0.91
Prognostic factors in superficial bladder cancer. World J Urol (1993) 0.89
Repeat mid-urethral sling for recurrent female stress urinary incontinence. Int Urogynecol J (2012) 0.88
Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology (1994) 0.88
[Transvaginal repair of genital prolapse using the Prolift technique: a prospective study]. Prog Urol (2010) 0.86
Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol (2000) 0.86
[IVU: a test of the past without future?]. Prog Urol (2001) 0.86
Course of pancreatic beta cell destruction in prediabetic NOD mice: a histomorphometric evaluation. Diabete Metab (1995) 0.86
Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urol (1993) 0.86
Acalculous cholecystitis and cytomegalovirus infection in a patient with AIDS. J Infect Dis (1987) 0.85
[Recommendations Onco-Urology 2010: Prostate cancer]. Prog Urol (2010) 0.85
Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma? Cancer (1996) 0.84
Renal carcinoma: diagnosis of venous invasion with Gd-enhanced MR venography. Eur Radiol (2000) 0.82
Hormonal and molecular genetic findings in 46,XX subjects with sexual ambiguity and testicular differentiation. Eur J Pediatr (1993) 0.81
[Features of prostatic cancer in French individuals of African-Caribbean origin]. Prog Urol (2000) 0.80
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001). Br J Cancer (2003) 0.79
Predictive value of pathological features for progression after radical prostatectomy. Eur Urol (1994) 0.79
[Primary T lymphoma of the bladder in a HIV infected patient]. Presse Med (1995) 0.78
[Treatment of ureteral stenosis using high pressure dilatation catheters]. Prog Urol (1997) 0.78
[The association of neuro-endocrine carcinoma of the skin and Bowen's disease. Review of the literature apropos of 4 cases]. Ann Pathol (1990) 0.78
[Effects of a 6F urethral catheter on uroflowmetry in men with benign prostatic hypertrophy]. Prog Urol (1998) 0.78
[Complete perineal prostatectomy carries an increased risk of capsular incision in healthy and cancerous tissue]. Prog Urol (1998) 0.78
[Status and medicolegal implications in France pT0 stage of prostate cancer: a study by the CC-AFU]. Prog Urol (2012) 0.78
A single positive prostate biopsy in six does not predict a low-volume prostate tumour. Br J Urol (1996) 0.77
[Immunohistochemical characteristics of malignant melanoma. A study of 40 cases and review of the literature]. Arch Anat Cytol Pathol (1990) 0.77
[Florid glandular cystitis: study of 3 cases and review of the literature]. Prog Urol (1998) 0.77
[Obliterative vaginal surgery for genital prolapse: a retrospective cases series]. Prog Urol (2012) 0.77
Adjuvant radiation therapy for recurrent PSA after radical prostatectomy in T1-T2 prostate cancer. Prostate Cancer Prostatic Dis (1998) 0.77
Limbal conjunctival Langerhans cell density in ocular cicatricial pemphigoid: an indirect immunofluorescence study on Dispase-split conjunctiva. Curr Eye Res (1997) 0.76
Role of preoperative positive apical biopsies in the prediction of specimen-confined prostate cancer after radical retropubic prostatectomy: a multi-institutional study. Eur Urol (2000) 0.76
[Can a precise vesiculectomy be performed during radical prostatectomy?]. Prog Urol (2001) 0.75
Diagnostic value of ten systematic TRUS-guided prostate biopsies. Eur Urol (1999) 0.75
Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels. Urology (1996) 0.75
Ocular involvement in Epstein-Barr virus-associated T-cell lymphoma. Am J Ophthalmol (1996) 0.75
Multiple molluscum contagiosum lesions of the limbus in a patient with HIV infection. Br J Ophthalmol (1995) 0.75
Fibroblast growth factors and their specific binding sites in normal urothelium and transitional cell carcinoma (TCC) of the human bladder. Cell Mol Biol (Noisy-le-grand) (1995) 0.75
Toxoplasmosis localized to the bladder is diagnostic of human immunodeficiency virus infection: case report. Clin Infect Dis (1996) 0.75
Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer. Br J Urol (1994) 0.75
[Innervation of Denonvilliers' recto-vesical septum. Anatomic study]. Morphologie (2002) 0.75
[Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml]. Presse Med (1996) 0.75
[Multicystic peritoneal mesothelioma. Ultrastructural and immunohistochemical study apropos of a case]. Ann Pathol (1985) 0.75
[Corneal epithelial diseases related to limbal stem cell deficiency]. J Fr Ophtalmol (2006) 0.75
[Post-prostatectomy radiotherapy: for which patients and when?]. Cancer Radiother (2002) 0.75
[A single positive prostatic biopsy out of six systematic biopsies is not correlated with the intracapsular nature of the tumor on an individual level]. Prog Urol (1996) 0.75
Pentamidine-induced dysglycaemia: experimental models in the rat. Diabete Metab (1993) 0.75
[Lymphoepithelial hyperplasia of the parotid gland and HIV infection]. Ann Otolaryngol Chir Cervicofac (1995) 0.75
[Papillary cystadenoma of the epididymis revealing von Hippel-Lindau disease]. Ann Pathol (2001) 0.75
Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy. Eur Urol (1997) 0.75
[Adenocarcinoma and primary osteosarcoma of the prostate. An unusual association]. Ann Pathol (1989) 0.75
[Salmonella pancreatic abscess. Treatment by drainage without cholecystectomy]. Gastroenterol Clin Biol (1990) 0.75
[Congenital stenosis of the esophagus due to tracheobronchial heterotopia. Review of the literature. Apropos of a case]. Ann Chir (1993) 0.75
[Anorectal Buschke-Löwenstein tumor (giant condylomatosis) requiring amputation of the rectum]. Gastroenterol Clin Biol (1989) 0.75
[Diagnostic value of 10 systematized and ultrasound-guided transrectal prostatic biopsies]. Prog Urol (1998) 0.75
[Surgical abdomen in the acquired immunodeficiency syndrome. Apropos of 4 cases]. Chirurgie (1985) 0.75
Immunoelectron microscopic study of the conjunctiva in cicatricial pemphigoid. Graefes Arch Clin Exp Ophthalmol (1999) 0.75
[Fatal fulminating anguilluliasis after corticotherapy and diabetic acidoketosis]. Ann Med Interne (Paris) (1989) 0.75
[Leiomyosarcoma of the esophagus 8 years after the diagnosis of a leiomyoma]. Gastroenterol Clin Biol (1991) 0.75
[Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen]. Schweiz Med Wochenschr (1996) 0.75
[Esophageal anomalies developed from tracheobronchial remnants. Reports of two cases with delayed diagnosis in adults]. Ann Pathol (1993) 0.75
[Results of the treatment of bladder tumors infiltrating the muscle]. Ann Urol (Paris) (1993) 0.75
[Recommendations for reforming prostatic specimens. Les Membres du Sous-Comité Prostate du Comité de Cancerologie de l'Association Française d'Urologie]. Ann Pathol (1999) 0.75
[Uterine perforation revealing a rare placental tumor: trophoblastic tumor of the implantation site. Review of the literature. Apropos of a case]. Rev Fr Gynecol Obstet (1989) 0.75
[Glucagonoma syndrome]. Ann Dermatol Venereol (1988) 0.75
[Innervation of Denonvilliers' recto-vesical fascia. Anatomical study]. Prog Urol (2000) 0.75
Advances in the assessment of clinically localized prostate cancer. Eur Urol (1996) 0.75
[Role of biological and anatomo-pathologic criteria in the prognosis evaluation of patients before and after radical prostatectomy]. Prog Urol (1994) 0.75
[Fibro-inflammatory polyp with eosinophilic infiltration. Apropos of 3 cases of gastric polyps]. Ann Pathol (1987) 0.75
[Does the proportion of tumor tissue in biopsies reflect the extent of localized prostate cancer?]. Prog Urol (1996) 0.75